Masimo Corp
NASDAQ:MASI

Watchlist Manager
Masimo Corp Logo
Masimo Corp
NASDAQ:MASI
Watchlist
Price: 172.96 USD 2.27% Market Closed
Market Cap: 9.3B USD
Have any thoughts about
Masimo Corp?
Write Note

Intrinsic Value

The intrinsic value of one MASI stock under the Base Case scenario is 128.09 USD. Compared to the current market price of 172.96 USD, Masimo Corp is Overvalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MASI Intrinsic Value
128.09 USD
Overvaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Masimo Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MASI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MASI?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Masimo Corp

Provide an overview of the primary business activities
of Masimo Corp.

What unique competitive advantages
does Masimo Corp hold over its rivals?

What risks and challenges
does Masimo Corp face in the near future?

Has there been any significant insider trading activity
in Masimo Corp recently?

Summarize the latest earnings call
of Masimo Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Masimo Corp.

Provide P/S
for Masimo Corp.

Provide P/E
for Masimo Corp.

Provide P/OCF
for Masimo Corp.

Provide P/FCFE
for Masimo Corp.

Provide P/B
for Masimo Corp.

Provide EV/S
for Masimo Corp.

Provide EV/GP
for Masimo Corp.

Provide EV/EBITDA
for Masimo Corp.

Provide EV/EBIT
for Masimo Corp.

Provide EV/OCF
for Masimo Corp.

Provide EV/FCFF
for Masimo Corp.

Provide EV/IC
for Masimo Corp.

Show me price targets
for Masimo Corp made by professional analysts.

What are the Revenue projections
for Masimo Corp?

How accurate were the past Revenue estimates
for Masimo Corp?

What are the Net Income projections
for Masimo Corp?

How accurate were the past Net Income estimates
for Masimo Corp?

What are the EPS projections
for Masimo Corp?

How accurate were the past EPS estimates
for Masimo Corp?

What are the EBIT projections
for Masimo Corp?

How accurate were the past EBIT estimates
for Masimo Corp?

Compare the revenue forecasts
for Masimo Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Masimo Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Masimo Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Masimo Corp compared to its peers.

Compare the P/E ratios
of Masimo Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Masimo Corp with its peers.

Analyze the financial leverage
of Masimo Corp compared to its main competitors.

Show all profitability ratios
for Masimo Corp.

Provide ROE
for Masimo Corp.

Provide ROA
for Masimo Corp.

Provide ROIC
for Masimo Corp.

Provide ROCE
for Masimo Corp.

Provide Gross Margin
for Masimo Corp.

Provide Operating Margin
for Masimo Corp.

Provide Net Margin
for Masimo Corp.

Provide FCF Margin
for Masimo Corp.

Show all solvency ratios
for Masimo Corp.

Provide D/E Ratio
for Masimo Corp.

Provide D/A Ratio
for Masimo Corp.

Provide Interest Coverage Ratio
for Masimo Corp.

Provide Altman Z-Score Ratio
for Masimo Corp.

Provide Quick Ratio
for Masimo Corp.

Provide Current Ratio
for Masimo Corp.

Provide Cash Ratio
for Masimo Corp.

What is the historical Revenue growth
over the last 5 years for Masimo Corp?

What is the historical Net Income growth
over the last 5 years for Masimo Corp?

What is the current Free Cash Flow
of Masimo Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Masimo Corp.

Business Breakdown

Masimo Corp. is a pioneering medical technology company that specializes in innovative non-invasive monitoring solutions. Founded in 1989 and headquartered in Irvine, California, Masimo revolutionized the field of patient monitoring with its groundbreaking pulse oximetry technology, which provides accurate blood oxygen saturation levels in a wide range of settings, from hospitals to home care. The company has continued to expand its product portfolio, introducing advanced monitoring solutions that measure multiple physiological parameters critical for patient care. With a strong emphasis on research and development, Masimo maintains a competitive edge, driving both innovation and customer lo...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Masimo Corp

Current Assets 1.3B
Cash & Short-Term Investments 158.5m
Receivables 444.6m
Other Current Assets 676.8m
Non-Current Assets 1.8B
Long-Term Investments 9.4m
PP&E 501m
Intangibles 1.1B
Other Non-Current Assets 244.2m
Current Liabilities 637.6m
Accounts Payable 280.8m
Accrued Liabilities 203.5m
Other Current Liabilities 153.3m
Non-Current Liabilities 987m
Long-Term Debt 733.2m
Other Non-Current Liabilities 253.8m
Efficiency

Earnings Waterfall
Masimo Corp

Revenue
2B USD
Cost of Revenue
-1B USD
Gross Profit
1B USD
Operating Expenses
-861.3m USD
Operating Income
161.1m USD
Other Expenses
-82.5m USD
Net Income
78.6m USD

Free Cash Flow Analysis
Masimo Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In the third quarter, Masimo reported healthcare revenue of $343 million, achieving 12% year-over-year growth, while non-healthcare revenue decreased by 6%. The company improved its consolidated non-GAAP gross margin to 54%, driven by operational efficiencies and manufacturing shifts to Malaysia, resulting in expected margins of 63% in Q4. For 2024, Masimo projects consolidated revenue between $2.75 billion and $2.85 billion, with healthcare growth between 9% to 10%. They aim for an EPS of $3.95 to $4.10, reflecting efficient expense management. The company's focus remains on long-term growth initiatives while managing its consumer business strategic review.

What is Earnings Call?
Fundamental Scores

MASI Profitability Score
Profitability Due Diligence

Masimo Corp's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Free Cash Flow
Positive Revenue Growth Forecast
52/100
Profitability
Score

Masimo Corp's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

MASI Solvency Score
Solvency Due Diligence

Masimo Corp's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Short-Term Solvency
Long-Term Solvency
53/100
Solvency
Score

Masimo Corp's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MASI Price Targets Summary
Masimo Corp

Wall Street analysts forecast MASI stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MASI is 172.51 USD with a low forecast of 146.45 USD and a high forecast of 199.5 USD.

Lowest
Price Target
146.45 USD
15% Downside
Average
Price Target
172.51 USD
0% Downside
Highest
Price Target
199.5 USD
15% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MASI?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MASI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MASI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

MASI News

Other Videos

Profile

Masimo Corp Logo
Masimo Corp

Country

United States of America

Industry

Health Care

Market Cap

9.3B USD

Dividend Yield

0%

Description

Masimo Corp. is a medical technology company, which develops, manufactures and markets noninvasive patient monitoring technologies, medical devices and sensors. The company is headquartered in Irvine, California and currently employs 2,200 full-time employees. The company went IPO on 2007-08-08. The firm's patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities and consumers through its direct sales force, distributors and original equipment manufacturer (OEM) partners. The company has developed Masimo Signal Extraction Technology (SET), which provides the capabilities of Measure-through Motion and Low Perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry. The firm's technology offerings also include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet and Masimo Patient SafetyNet Surveillance.

Contact

CALIFORNIA
Irvine
52 Discovery
+19492977000.0
www.masimo.com

IPO

2007-08-08

Employees

2 200

Officers

Founder & CEO
Mr. Joseph E. Kiani
Executive VP & CFO
Mr. Micah Young
Chief Operating Officer
Mr. Bilal Muhsin
Executive VP, General Counsel & Corporate Secretary
Mr. Thomas Samuel McClenahan
Executive Vice President of Business Development
Mr. Tao Leopold Levy
Senior VP & Chief Accounting Officer
Mr. Paul Hataishi
Show More
Executive VP & Chief Information Officer
Mr. Yongsam Lee
Chairman of Scientific Advisory Board & Chief Science Officer
Dr. Steven J. Barker
Vice President of Business Development & Investor Relations
Mr. Eli Kammerman
Executive Vice President of Operations & Clinical Research
Mr. Anand Sampath
Show Less

See Also

Discover More
What is the Intrinsic Value of one MASI stock?

The intrinsic value of one MASI stock under the Base Case scenario is 128.09 USD.

Is MASI stock undervalued or overvalued?

Compared to the current market price of 172.96 USD, Masimo Corp is Overvalued by 26%.

Back to Top